Loomis, Sayles & Company’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-862,710
Closed -$51M 1016
2021
Q4
$51M Sell
862,710
-21,969
-2% -$1.52M 0.06% 143
2021
Q3
$58.8M Buy
884,679
+66,897
+8% +$4.13M 0.07% 121
2021
Q2
$51.6M Buy
817,782
+52,221
+7% +$2.94M 0.06% 142
2021
Q1
$39.8M Sell
765,561
-2,351
-0.3% -$143K 0.05% 190
2020
Q4
$33.7M Sell
767,912
-4,500
-0.6% -$214K 0.04% 188
2020
Q3
$36.6M Buy
772,412
+140,803
+22% +$5.7M 0.05% 141
2020
Q2
$19.1M Buy
+631,609
New +$14.1M 0.03% 225

Other funds holding CYRX

Loomis, Sayles & Company's CYRX Position: Q1 2022 in Review

Loomis, Sayles & Company sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 862,710 shares — an estimated $51M sold.

Loomis, Sayles & Company first reported a position in CYRX in Q2 2020 and held it in 7 quarters. The position peaked at $58.8M in Q3 2021. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

  • Loomis, Sayles & Company reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 862,710 CryoPort shares in Q1 2022, an estimated $51M.
  • Loomis, Sayles & Company first reported a position in CryoPort in Q2 2020 and held it in 7 quarters.
  • Loomis, Sayles & Company's CryoPort position peaked at $58.8M in Q3 2021.
  • 200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Loomis, Sayles & Company's 13F filing for Q1 2022, filed 13 May 2022.